Marcus Vinícius de Andrade Barros

Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)

Raoni Pais Siqueira, Éverton de Almeida Alves Barbosa, Marcelo D. Polêto et al. · PLoS ONE · 2015 · 77 citations · Full text

Pharmaceutical Science, Chemoprevention Strategy, Srpk Inhibition +19

Trifluoromethyl arylamides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs)

Raoni Pais Siqueira, Marcus Vinícius de Andrade Barros, Éverton de Almeida Alves Barbosa et al. · European Journal of Medicinal Chemistry · 2017 · 24 citations

Pharmaceutical Chemistry, Biochemistry, Antileukemia Effect +7

Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma

Gabriela Alves Moreira, Graziela Domingues de Almeida Lima, Raoni Pais Siqueira et al. · Toxicology and Applied Pharmacology · 2018 · 21 citations

Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells

Raoni Pais Siqueira, Mônica Maria Magalhães Caetano, Luciana Ângelo de Souza et al. · Toxicology in Vitro · 2020 · 19 citations

The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice

Gabriela Alves Moreira, Mônica Maria Magalhães Caetano, Juliana A. Vale et al. · Biochemical Pharmacology · 2022 · 12 citations